MetaADEDB 2.0 @ LMMD
alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination
(LCWAOCHOPBSGMU-UHFFFAOYSA-J)
Structure
SMILES
[O-]C(=O)O.[O-2].[Na+].[Mg+2].[OH-].[OH-].[OH-].[Al+3].[Si]
Molecular Formula:
CH4AlMgNaO7Si
Molecular Weight:
230.400
Log P:
-2.1423
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
4
TPSA:
129.54
CAS Number(s):
66220-44-8
Synonym(s)
1.
alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination
2.
Gastrocote
3.
Gaviscon
4.
Quigel
5.
alginate - aluminium hydroxide - magnesium trisilicate - sodium bicarbonate
External Link(s)
MeSHC007829
PubChem Compound6336690
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 12
Canada Vigilance: 1		Canada Vigilance
US FAERS
2Drug administration errorFAERS: 8US FAERS
3DysgeusiaFAERS: 7US FAERS
4NauseaFAERS: 5US FAERS
5Oral painFAERS: 5US FAERS
6Throat irritationFAERS: 5US FAERS
7Blood glucose increasedFAERS: 4US FAERS
8Drug effective for unapproved indicationFAERS: 4US FAERS
9Gingival discomfortFAERS: 4US FAERS
10StomatitisFAERS: 4US FAERS
11DyspepsiaFAERS: 39570261CTD
OFFSIDES
US FAERS
12Incorrect product administration durationFAERS: 3US FAERS
13LacerationFAERS: 3US FAERS
14MalaiseFAERS: 3US FAERS
15Product package associated injuryFAERS: 3US FAERS
16Product quality issueFAERS: 3US FAERS
17Product use in unapproved indicationFAERS: 3US FAERS
18Product use issueFAERS: 3US FAERS
19Abdominal discomfortFAERS: 2OFFSIDES
US FAERS
20Accidental exposure to productFAERS: 2US FAERS
21DiscomfortFAERS: 2US FAERS
22Electrocardiogram abnormalFAERS: 2US FAERS
23Expired product administeredFAERS: 2US FAERS
24Feeling abnormalFAERS: 2US FAERS
25FlatulenceFAERS: 2US FAERS
26Incorrect dose administeredFAERS: 2US FAERS
27NephrolithiasisFAERS: 2US FAERS
28NervousnessFAERS: 2US FAERS
29Oropharyngeal discomfortFAERS: 2US FAERS
30PainFAERS: 2
Canada Vigilance: 1		Canada Vigilance
US FAERS
31VomitingFAERS: 2
Canada Vigilance: 1		Canada Vigilance
US FAERS
32Accidental exposure to product by childFAERS: 1US FAERS
33AnxietyFAERS: 1US FAERS
34Back PainFAERS: 1US FAERS
35Blood creatine phosphokinase increasedFAERS: 1US FAERS
36Blunted affectFAERS: 1US FAERS
37CheilitisFAERS: 1US FAERS
38Chemical burn of gastrointestinal tractFAERS: 1US FAERS
39Chest PainFAERS: 1US FAERS
40Chest discomfortFAERS: 1US FAERS
41ChokingFAERS: 1US FAERS
42Dental cariesFAERS: 1US FAERS
43Drug dose omissionFAERS: 1US FAERS
44Drug ineffective for unapproved indicationFAERS: 1US FAERS
45Expired drug administeredFAERS: 1US FAERS
46FatigueFAERS: 1US FAERS
47Feeling jitteryFAERS: 1US FAERS
48Foreign body in respiratory tractFAERS: 1US FAERS
49Gastric BypassFAERS: 1US FAERS
50Gastric infectionFAERS: 1US FAERS
51Gastrointestinal ulcerFAERS: 1US FAERS
52GlossitisFAERS: 1US FAERS
53Incorrect drug administration durationFAERS: 1US FAERS
54Incorrect route of drug administrationFAERS: 1US FAERS
55InflammationFAERS: 1US FAERS
56Intentional drug misuseFAERS: 1US FAERS
57Intentional product misuseFAERS: 1US FAERS
58Medication ErrorFAERS: 1US FAERS
59Metabolic acidosisFAERS: 1OFFSIDES
US FAERS
60Musculoskeletal discomfortFAERS: 1US FAERS
61MyalgiaFAERS: 1US FAERS
62Neck PainFAERS: 1US FAERS
63Oral mucosal erythemaFAERS: 1US FAERS
64Oropharyngeal painFAERS: 1US FAERS
65OverdoseFAERS: 1US FAERS
66Pancreatic carcinomaFAERS: 1US FAERS
67Product taste abnormalFAERS: 1US FAERS
68RegurgitationFAERS: 1OFFSIDES
US FAERS
69RetchingFAERS: 1US FAERS
70Therapeutic response unexpectedFAERS: 1US FAERS
71ThirstFAERS: 1US FAERS
72Tongue erythemaFAERS: 1US FAERS
73Wrong technique in drug usage processFAERS: 1US FAERS
74Wrong technique in product usage processFAERS: 1US FAERS
75Abdominal Pain9570261CTD
OFFSIDES
76AbscessOFFSIDES
77Acid refluxOFFSIDES
78AcidosisOFFSIDES
79Acute Coronary SyndromeOFFSIDES
80Acute myocardial infarctionOFFSIDES
81Alanine aminotransferase abnormalOFFSIDES
82Altered state of consciousnessOFFSIDES
83Anal discomfortOFFSIDES
84AneurysmOFFSIDES
85AngioedemaOFFSIDES
86Ankylosing spondylitisOFFSIDES
87Anticonvulsant drug level below therapeuticOFFSIDES
88Antidepressant drug clearance decreasedOFFSIDES
89Antiviral drug level above therapeuticOFFSIDES
90ApathyOFFSIDES
91AppendicitisOFFSIDES
92Application site irritationOFFSIDES
93Arteriopathic diseaseOFFSIDES
94Aseptic MeningitisOFFSIDES
95AsphyxiaOFFSIDES
96AsterixisOFFSIDES
97AsthmaOFFSIDES
98AtelectasisOFFSIDES
99AthetosisOFFSIDES
100Atrial FlutterOFFSIDES
101Atrioventricular Septal DefectOFFSIDES
102Autoimmune neutropeniaOFFSIDES
103Autoimmune thrombocytopeniaOFFSIDES
104Blood chloride decreasedOFFSIDES
105Blood glucose decreasedOFFSIDES
106Blood glucose fluctuationOFFSIDES
107Blood pressure fluctuationOFFSIDES
108Blood sodiumOFFSIDES
109Bone marrow toxicityOFFSIDES
110BronchiolitisOFFSIDES
111BronchoscopyOFFSIDES
112BulimiaOFFSIDES
113Cardio-respiratory distressOFFSIDES
114Catheter related complicationOFFSIDES
115Cerebellar AtaxiaOFFSIDES
116Cerebral PalsyOFFSIDES
117Cerebral atrophyOFFSIDES
118Choking sensationOFFSIDES
119CholangiolitisOFFSIDES
120ChromaturiaOFFSIDES
121Chronic respiratory failureOFFSIDES
122ColitisOFFSIDES
123Concomitant disease progressionOFFSIDES
124ConstipationCanada Vigilance: 1Canada Vigilance
125Coronary artery insufficiencyOFFSIDES
126CraniosynostosisOFFSIDES
127CryptorchidismOFFSIDES
128CyanosisOFFSIDES
129Cytolytic hepatitisOFFSIDES
130Delayed deliveryOFFSIDES
131Difficult to wean from ventilatorOFFSIDES
132Diffuse alveolar damageOFFSIDES
133Disease recurrenceOFFSIDES
134Drug exposure during pregnancyOFFSIDES
135Duodenal UlcerOFFSIDES
136Duodenal ulcer perforationOFFSIDES
137DuodenitisOFFSIDES
138Echoencephalogram abnormalOFFSIDES
139Economic problemOFFSIDES
140Eczema weepingOFFSIDES
141EczemaOFFSIDES
142EmpyemaOFFSIDES
143EpiduritisOFFSIDES
144EpilepsyOFFSIDES
145ErythropeniaOFFSIDES
146Escherichia infectionOFFSIDES
147Escherichia sepsisOFFSIDES
148Facial NeuralgiaOFFSIDES
149Fatty LiverOFFSIDES
150Febrile bone marrow aplasiaOFFSIDES
151GalactostasisOFFSIDES
152Gastrointestinal motility disorderOFFSIDES
153General physical health deteriorationOFFSIDES
154GranulocytosisOFFSIDES
155Hay feverOFFSIDES
156Headache9570261CTD
157Heartburn9570261CTD
158HemiparesisOFFSIDES
159Heparin-induced thrombocytopeniaOFFSIDES
160Hepatitis B positiveOFFSIDES
161HepatitisOFFSIDES
162HerniaOFFSIDES
163Hip DysplasiaOFFSIDES
164Hyperemesis GravidarumOFFSIDES
165HypospadiasOFFSIDES
166HypoxiaOFFSIDES
167Iatrogenic injuryOFFSIDES
168Idiosyncratic drug reactionOFFSIDES
169ImmobileOFFSIDES
170Increased bronchial secretionOFFSIDES
171Increased upper airway secretionOFFSIDES
172Infrequent bowel movementsOFFSIDES
173Injection site erythemaOFFSIDES
174Intervertebral Disc DegenerationOFFSIDES
175Joint injuryOFFSIDES
176Lactation DisorderOFFSIDES
177LaryngospasmOFFSIDES
178Leukopenia neonatalOFFSIDES
179Malignant melanoma in situOFFSIDES
180Malignant neoplasm progressionOFFSIDES
181Mallory-Weiss SyndromeOFFSIDES
182Mechanical ventilationOFFSIDES
183Medication residueOFFSIDES
184MesotheliomaOFFSIDES
185MetatarsalgiaOFFSIDES
186Multiple MyelomaOFFSIDES
187Myasthenia GravisOFFSIDES
188Myeloid maturation arrestOFFSIDES
189Nephritic syndromeOFFSIDES
190Neutropenic sepsisOFFSIDES
191Nipple painOFFSIDES
192Non-cardiac chest painOFFSIDES
193Nonspecific reactionOFFSIDES
194OligohydramniosOFFSIDES
195Oral mucosal exfoliationOFFSIDES
196Oropharyngeal blisteringOFFSIDES
197OsteoporosisOFFSIDES
198PallorOFFSIDES
199ParotitisOFFSIDES
200Performance status decreasedOFFSIDES
201Perianal abscessOFFSIDES
202Pericardial effusionOFFSIDES
203Peritoneal cloudy effluentOFFSIDES
204PeritonitisOFFSIDES
205Pleural MesotheliomaOFFSIDES
206Pleural decorticationOFFSIDES
207Pneumococcal sepsisOFFSIDES
208Post procedural cellulitisOFFSIDES
209Post procedural complicationOFFSIDES
210Pre-EclampsiaOFFSIDES
211Pregnancy after post coital contraceptionOFFSIDES
212Pregnancy of partnerOFFSIDES
213Productive CoughOFFSIDES
214Prothrombin time abnormalOFFSIDES
215PsoriasisOFFSIDES
216Psychiatric decompensationOFFSIDES
217Pulmonary InfarctionOFFSIDES
218Pulmonary Valve StenosisOFFSIDES
219PurulenceOFFSIDES
220Radiation FibrosisOFFSIDES
221RalesOFFSIDES
222Respiratory FailureOFFSIDES
223RhinalgiaOFFSIDES
224Rubella antibody positiveOFFSIDES
225ScotomaOFFSIDES
226Sensorimotor disorderOFFSIDES
227Septic ShockOFFSIDES
228SplenectomyOFFSIDES
229Staphylococcal abscessOFFSIDES
230Stem cell transplantOFFSIDES
231Subcutaneous noduleOFFSIDES
232Sudden deathOFFSIDES
233Superficial ThrombophlebitisOFFSIDES
234Supraventricular tachycardiaOFFSIDES
235TachycardiaCanada Vigilance: 1Canada Vigilance
236TalipesOFFSIDES
237TenosynovitisOFFSIDES
238Therapy non-responderOFFSIDES
239Tinea PedisOFFSIDES
240Toxoplasma serologyOFFSIDES
241Tracheal fistulaOFFSIDES
242Troponin increasedOFFSIDES
243Umbilical herniaOFFSIDES
244Ventricular hypoplasiaOFFSIDES
245Walking aid userOFFSIDES
246Wheelchair userOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.